BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 31385729)

  • 1. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Ramezani Tehrani F; Amiri M; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
    Gynecol Endocrinol; 2020 Jan; 36(1):12-23. PubMed ID: 31385729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression.
    Amiri M; Ramezani Tehrani F; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
    Reprod Biol Endocrinol; 2020 Mar; 18(1):23. PubMed ID: 32183820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study.
    Mani H; Levy MJ; Davies MJ; Morris DH; Gray LJ; Bankart J; Blackledge H; Khunti K; Howlett TA
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):926-34. PubMed ID: 23046078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study.
    Berni TR; Morgan CL; Rees DA
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3369-e3380. PubMed ID: 34061968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Polycystic Ovary Syndrome on Silent Coronary Artery Disease and Cardiovascular Events; A Long-term Population-based Cohort Study.
    Mahboobifard F; Rahmati M; Niknam A; Rojhani E; Momenan AA; Azizi F; Ramezani Tehrani F
    Arch Med Res; 2022 Apr; 53(3):312-322. PubMed ID: 34823887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of cardiovascular events in patients with polycystic ovary syndrome.
    Iftikhar S; Collazo-Clavell ML; Roger VL; St Sauver J; Brown RD; Cha S; Rhodes DJ
    Neth J Med; 2012 Mar; 70(2):74-80. PubMed ID: 22418753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
    Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
    Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies.
    Zhang J; Xu JH; Qu QQ; Zhong GQ
    Front Cardiovasc Med; 2020; 7():552421. PubMed ID: 33282917
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States.
    Dwivedi AK; Vishwakarma D; Dubey P; Reddy S
    Eur J Endocrinol; 2023 Jun; 188(6):555-563. PubMed ID: 37307574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
    Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
    Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis.
    Behboudi-Gandevani S; Amiri M; Bidhendi Yarandi R; Noroozzadeh M; Farahmand M; Rostami Dovom M; Ramezani Tehrani F
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):169-184. PubMed ID: 28930378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.
    Millán-de-Meer M; Luque-Ramírez M; Nattero-Chávez L; Escobar-Morreale HF
    Hum Reprod Update; 2023 Nov; 29(6):741-772. PubMed ID: 37353908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study.
    Chang AY; Oshiro J; Ayers C; Auchus RJ
    Clin Endocrinol (Oxf); 2016 Jul; 85(1):92-9. PubMed ID: 26608823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study.
    Behboudi-Gandevani S; Ramezani Tehrani F; Hosseinpanah F; Khalili D; Cheraghi L; Kazemijaliseh H; Azizi F
    Fertil Steril; 2018 Dec; 110(7):1377-1386. PubMed ID: 30503137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification.
    Osibogun O; Ogunmoroti O; Kolade OB; Hays AG; Okunrintemi V; Minhas AS; Gulati M; Michos ED
    J Womens Health (Larchmt); 2022 Jun; 31(6):762-771. PubMed ID: 35575750
    [No Abstract]   [Full Text] [Related]  

  • 18. Comprehensive evaluation of disparities in cardiometabolic and reproductive risk between Hispanic and White women with polycystic ovary syndrome in the United States: a systematic review and meta-analysis.
    Kazemi M; Kim JY; Wan C; Xiong JD; Parry SA; Azziz R; Lujan ME
    Am J Obstet Gynecol; 2022 Feb; 226(2):187-204.e15. PubMed ID: 34384776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
    Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
    Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria-a prospective population-based cohort study.
    Ollila MM; Arffman RK; Korhonen E; Morin-Papunen L; Franks S; Junttila J; Piltonen TT
    Eur J Endocrinol; 2023 Jul; 189(1):96-105. PubMed ID: 37436934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.